Receptor Ck-dependent signaling regulates hTERT gene trascription

BMC Cell Biology

Volumn 7, Issue , 2006, Pages

  Sikand, Kavleen ^a   Kaul, Deepak ^a   Varma, Neelam ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYCHOLESTEROL; CELL SURFACE RECEPTOR; CHOLESTEROL; CYCLIN D; MESSENGER RNA; MYC PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PIOGLITAZONE; PROTEIN BCL 2; PROTEIN KINASE C; RECEPTOR CK; TELOMERASE REVERSE TRANSCRIPTASE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; GENE EXPRESSION; GENETIC CODE; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MOLECULAR MECHANICS; ONCOGENE C MYC; PERIPHERAL BLOOD MONONUCLEAR CELL; RECEPTOR DOWN REGULATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

EID: 31844454170     PISSN: 14712121     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2121-7-2     Document Type: Article

References (55)

1. de Lange T: Telomeres. Nature 1998, 392:753-754.
2. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PLC, Coviello GM, Wright WE, Weinrich SL, Shay JW: Specific association of human telomerase activity with immortal cells and cancer. Science 1994, 266:2011-2015.
3. Shay JW, Bacchetti S: A survey of telomerase activity in human cancer. Eur J Cancer 1997, 33:787-791.
4. Krupp G, Klapper W, Parwaresch R: Cell proliferation, carcinogenesis and diverse mechanisms of telomerase regulation. Cell Mol Life Sci 2000, 57:464-486.
5. Harley CB, Futcher AB, Greider CW: Telomeres shorten during ageing of human fibroblasts. Nature 1990, 345:458-460.
6. Lindsey J, McGill NI, Lindsey LA, Green DK, Crooke HJ: In vivo loss of telomeric repeats with age in humans. Mutat Res 1991, 256:45-48.
7. Cong Y, Wright WE, Shay JW: Human telomerase and its regulation. Microbiol Mol Biol Rev 2002, 66:407-425.
8. Yin L, Hubbard AK, Giardina C: NF-κB regulates transcription of the mouse telomerase catalytic subunit. J Biol Chem 2000, 275:36671-36675.
9. Wang W, Luo HS, Yu BP: Expression of NF-κB and human telomerase reverse transcriptase in gastric cancer and precancerous lesions. World J Gastroenterol 2004, 10:177-181.
10. Mandal M, Kumar R: Bcl-2 modulates telomerase activity. J Biol Chem 1997, 272:14183-14187.
11. Fu W, Begley JG, Killen MW, Mattson MP: Anti-apoptotic role of telomerase in pheochromocytoma cells. J Biol Chem 1999, 274:7264-7271.
12. Horikawa I, Barrett JC: Transcriptional regulation of the telomerase hTERT gene as a target for cellular and viral oncogenic mechanisms. Carcinogenesis 2003, 24:1167-176.
13. k activation-response coupling in human platelets. Platelets 1995, 6:306-309.
14. Kaul D: Cholesterol-receptor-mediated genomics in health and disease. Trends Mol Med 2003, 9:442-449.
15. k deficiency initiate leukemia? Cancer Lett 1997, 112:199-202.
16. Kaul D, Khosla VK: Molecular basis of cholesterol feedback lesion in CNS tumors. Neurology India 2000, 48:174-177.
17. Bartkova J, Zemanova M, Bartek J: Abundance and subcellular localization of cyclin D3 in human tumors. Int J Cancer 1996, 65:323-327.
18. Lammie GA, Peters G: Chromosome 11q13 abnormalities in human cancer. Cancer Cells 1991, 3:413-420.
19. Fajas L, Debril MB, Auwerx J: Peroxisome proliferator - activated receptor - γ from adipogenesis to carcinogenesis. J Mol Endocrinol 2001, 27:1-9.
20. Sporn MB, Suh N, Mangelsdorf DJ: Prospects for prevention and treatment of cancer with selective PPAR γ modulators (SPARMs). Trends Mol Med 2001, 7:395-400.
21. Ranganathan S, Hattori H, Kashyap ML: A rapid flow cytometric assay for low-density lipoprotein receptors in human peripheral blood mononuclear cells. J Lab Clin Med 1995, 125:479-486.
22. k and leukemogenesis. Leuk Res 1998, 22:389-394.
23. Ayala-Torres S, Zhou F, Thompson EB: Apoptosis induced by oxysterol in CEM cells is associated with negative regulation of c-myc. Exp Cell Res 1999, 246:193-202.
24. Rumi MAK, Sato H, Ishihara S, Kawashima K, Hamamoto S, Kazumori H, Okuyama T, Fukuda R, Nagasue N, Kinoshita Y: Peroxisome proliferator-activated receptor γ ligand-induced growth inhibition of human hepatocellular carcinoma. Br J Cancer 2001, 84:1640-1647.
25. Brindley DN: Intracellular translocation of phosphatidate phosphohydrolase and its possible role in the control of glycerolipid synthesis. Prog Lipid Res 1984, 23:115-133.
26. Huy H, Sarre TF: Protein kinase C isoenzymes: divergence in signal transduction? Biochem J 1993, 291:329-343.
27. Nishizuka Y: The role of protein kinase C in cell surface signal transduction and tumor promotion. Nature 1984, 308:693-697.
28. Ricote M, Huang J, Fajas L, Li A, Welch J, Najib J, Witztum JL, Auwerx J, Palmski W, Glass CK: Expression of the peroxisome proliferator-activated receptor γ (PPARγ) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein. Proc Natl Acad Sci USA 1998, 95:7614-7619.
29. 2 activation. Arch Biochem Biophys 2000, 378:246-258.
30. Feng J, Han J, Pearce SF, Silverstein RL, Gotto AM Jr, Hajjar DP, Nicholson AC: Induction of CD36 expression by oxidised LDL and IL-4 by a common signaling pathway dependent on protein kinase C and PPAR-γ. J Lipid Res 2000, 41:688-696.
31. Nicholson AC, Febbraio M, Han J, Silverstein RL, Hajjar DP: CD36 in atherosclerosis. The role of a class B macrophage scavenger receptor. Ann NY Acad Sci 2000, 902:128-131.
32. Yip-Schneider MT, Horie M, Broxmeyer HE: Characterization of interleukin-7-induced changes in tyrosine phosphorylation and c-myc gene expression in normal human T cells. Exp Hematol 1993, 21:1648-1656.
33. Kim YW, Hur SY, Kim TE, Lee JM, Namkoong SE, Ki IK, Kim JW: Protein kinase C modulates telomerase activity in human cervical cancer cells. Exp Mol Med 2001, 33:156-163.
34. Shimada T, Kojima K, Yoshiura K, Hiraishi H, Tarano A: Characteristics of the peroxisome proliferator activated receptor γ (PPARγ) ligand induced apoptosis in colon cancer cells. Gut 2002, 50:658-664.
35. Yamakawa-Karakida N, Sugita K, Inukai T, Goi K, Nakamura M, Uno K, Sato H, Kagami K, Barker N, Nakazawa S: Ligand activation of peroxisome proliferator-activated receptor γ induces apoptosis of leukemia cells by down-regulating the c-myc gene expression via blockade of the tcf-4 activity. Cell Death Differ 2002, 9:513-526.
36. Sugawara A, Takeuchi K, Uruno A, Ikeda Y, Arima S, Kudo M, Sato K, Taniyama Y, Ito S: Transcriptional suppression of type 1 angiotensin II receptor gene expression by peroxisome proliferator-activated receptor-γ in vascular smooth muscle cells. Endocrinology 2001, 142:3125-3134.
37. Sugawara A, Uruno A, Kudo M, Ikeda Y, Sato K, Taniyama Y, Ito S, Takeuchi K: Transcriptional suppression of thromboxane receptor gene by peroxisome proliferator-activated receptor-γ via an interaction with Sp 1 in vascular smooth muscle cells. J Biol Chem 2002, 277:9676-9683.
38. Ricote M, Li AC, Willson TM, Kelly CJ, Glass CK: The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation. Nature 1998, 391:79-82.
39. Su CG, Wen X, Bailey ST, Jiang W, Rangwala SM, Keilbaugh SA, Flanigan A, Murthy S, Lazar MA, Wu GD: A novel therapy for colitis utilizing PPAR-γ ligands to inhibit the epithelial inflammatory response. J Clin Invest 1999, 104:383-389.
40. Vamecq J, Latruffe N: Medical significance of peroxisome proliferator-activated receptors. Lancet 1999, 354:141-148.
41. Schlezinger JJ, Jensen BA, Mann KK, Ryu HY, Sherr DH: Peroxisome proliferator-activated receptor γ mediated NF-κB activation and apoptosis in pre-B cells. J Immunol 2002, 169:6831-6841.
42. k-dependent regulation of genes involved in the cell cycle. Mol Cell Biochem 1998, 181:137-142.
43. . Schroepfer GJ JR: Oxysterols: modulators of cholesterol metabolism and other processes. Physiol Rev 2000, 80:361-554.
44. . Chiang JYL: Bile acid regulation of gene expression: roles of nuclear hormone receptors. Endocr Rev 2002, 23:443-463.
45. Slagbloom PE, Droog S, Boomsma DI: Genetic determination of telomere size in humans: a twin study of three age groups. Am J Hum Genet 1994, 55:876-882.
46. Rufer N, Dragowska W, Thornbury G, Roosnek E, Lansdorp PM: Telomere length dynamics in human lymphocyte subpopulations measured by flow cytometry. Nat Biotechnol 1998, 16:743-747.
47. Liu K, Schoonmaker MM, Levine BL, June CH, Hodes RJ, Weng N: Constitutive and regulated expression of telomerase reverse transcriptase (hTERT) in human lymphocytes. Proc Natl Acad Sci USA 1999, 96:5147-5152.
48. Chang S, DePinho RA: Telomerase extracurricular activities. Proc Natl Acad Sci USA 2002, 99:12520-12522.
49. Kaul D, Kaur M: LDL- dependent regulation of Bcl-2 and cyclin 'D' gene expression in lymphocytes from normal and CML patients. Cancer Lett 1997, 119:131-135.
50. Boyum A: Ficoll-Hypaque method for separating mononuclear cells and granulocytes from human blood. Scand J Clin Lab Invest 1968:57-62.
51. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987, 162:156-159.
52. Auboeuf D, Rieusset J, Fajas L, Vallier P, Frering V, Riou JP, Staels B, Auwerx J, Laville M, Vidal H: Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-α in humans. No alteration in adipose tissue of obese and NIDDM patients. Diabetes 1997, 46:1319-1327.
53. Nakamura TM, Morin GB, Chapman KB, Weinrich SL, Andrews WH, Lingner J, Harley CB, Cech TR: Telomerase catalytic subunit homologs from fission yeast and human. Science 1997, 277:955-959.
54. Xu D, Gruber A, Peterson C, Pisa P: Telomerase activity and the expression of telomerase components in acute myelogenous leukemia. Br J Haematol 1998, 102:1367-1375.
55. Kiaris H, Schally AV: Decrease in telomerase activity in U-87MG human glioblastomas after treatment with an antagonist of growth hormone-releasing hormone. Proc Natl Acad Sci USA 1999, 96:226-231.